These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 9799653

  • 1. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J, Boknik P, DePaoli-Roach AA, Field LJ, Rockman HA, Kobayashi YM, Kelley JS, Jones LR.
    J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of the Na(+)-Ca2+ exchanger leads to enhanced inotropic responsiveness to Na(+)-channel agonist without sarcoplasmic reticulum protein changes in transgenic mice.
    Bäumer AT, Flesch M, Kilter H, Philipson KD, Böhm M.
    Biochem Biophys Res Commun; 1998 Aug 28; 249(3):786-90. PubMed ID: 9731214
    [Abstract] [Full Text] [Related]

  • 3. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
    Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, Kranias EG.
    J Clin Invest; 1996 Jan 15; 97(2):533-9. PubMed ID: 8567978
    [Abstract] [Full Text] [Related]

  • 4. Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species.
    Lüss I, Boknik P, Jones LR, Kirchhefer U, Knapp J, Linck B, Lüss H, Meissner A, Müller FU, Schmitz W, Vahlensieck U, Neumann J.
    J Mol Cell Cardiol; 1999 Jun 15; 31(6):1299-314. PubMed ID: 10371704
    [Abstract] [Full Text] [Related]

  • 5. Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein.
    Rockman HA, Hamilton RA, Jones LR, Milano CA, Mao L, Lefkowitz RJ.
    J Clin Invest; 1996 Apr 01; 97(7):1618-23. PubMed ID: 8601626
    [Abstract] [Full Text] [Related]

  • 6. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
    Gramolini AO, Trivieri MG, Oudit GY, Kislinger T, Li W, Patel MM, Emili A, Kranias EG, Backx PH, Maclennan DH.
    Proc Natl Acad Sci U S A; 2006 Feb 14; 103(7):2446-51. PubMed ID: 16461894
    [Abstract] [Full Text] [Related]

  • 7. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
    Brittsan AG, Kiss E, Edes I, Grupp IL, Grupp G, Kranias EG.
    J Mol Cell Cardiol; 1999 Sep 14; 31(9):1725-37. PubMed ID: 10471356
    [Abstract] [Full Text] [Related]

  • 8. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
    Dash R, Frank KF, Carr AN, Moravec CS, Kranias EG.
    J Mol Cell Cardiol; 2001 Jul 14; 33(7):1345-53. PubMed ID: 11437540
    [Abstract] [Full Text] [Related]

  • 9. Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger.
    Linck B, Bokník P, Huke S, Kirchhefer U, Knapp J, Lüss H, Müller FU, Neumann J, Tanriseven Z, Vahlensieck U, Baba HA, Jones LR, Philipson KD, Schmitz W.
    J Pharmacol Exp Ther; 2000 Aug 14; 294(2):648-57. PubMed ID: 10900244
    [Abstract] [Full Text] [Related]

  • 10. Phospholamban modulates murine atrial contractile parameters and responses to beta-adrenergic agonists.
    Kadambi VJ, Koss KL, Grupp IL, Kranias EG.
    J Mol Cell Cardiol; 1998 Jul 14; 30(7):1275-84. PubMed ID: 9710796
    [Abstract] [Full Text] [Related]

  • 11. Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.
    Movsesian MA, Colyer J, Wang JH, Krall J.
    J Clin Invest; 1990 May 14; 85(5):1698-702. PubMed ID: 2139670
    [Abstract] [Full Text] [Related]

  • 12. Phospholamban and cardiac contractility.
    Frank K, Kranias EG.
    Ann Med; 2000 Nov 14; 32(8):572-8. PubMed ID: 11127935
    [Abstract] [Full Text] [Related]

  • 13. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
    El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D.
    Circulation; 2006 Aug 15; 114(7):670-80. PubMed ID: 16894034
    [Abstract] [Full Text] [Related]

  • 14. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle.
    Szentesi P, Pignier C, Egger M, Kranias EG, Niggli E.
    Circ Res; 2004 Oct 15; 95(8):807-13. PubMed ID: 15388639
    [Abstract] [Full Text] [Related]

  • 15. Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists.
    Kirchhefer U, Jones LR, Begrow F, Boknik P, Hein L, Lohse MJ, Riemann B, Schmitz W, Stypmann J, Neumann J.
    Cardiovasc Res; 2004 Apr 01; 62(1):122-34. PubMed ID: 15023559
    [Abstract] [Full Text] [Related]

  • 16. Phospholamban: a crucial regulator of cardiac contractility.
    MacLennan DH, Kranias EG.
    Nat Rev Mol Cell Biol; 2003 Jul 01; 4(7):566-77. PubMed ID: 12838339
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes.
    Antipenko AY, Spielman AI, Sassaroli M, Kirchberger MA.
    Biochemistry; 1997 Oct 21; 36(42):12903-10. PubMed ID: 9335549
    [Abstract] [Full Text] [Related]

  • 18. Relationship between phospholamban and nucleotide activation of cardiac sarcoplasmic reticulum Ca2+ adenosinetriphosphatase.
    Coll KE, Johnson RG, McKenna E.
    Biochemistry; 1999 Feb 23; 38(8):2444-51. PubMed ID: 10029538
    [Abstract] [Full Text] [Related]

  • 19. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
    Mørk HK, Sjaastad I, Sande JB, Periasamy M, Sejersted OM, Louch WE.
    J Mol Cell Cardiol; 2007 Aug 23; 43(2):177-86. PubMed ID: 17574269
    [Abstract] [Full Text] [Related]

  • 20. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
    Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG.
    Circ Res; 1994 Sep 23; 75(3):401-9. PubMed ID: 8062415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.